BR9510162A - Medicamento para influenciar afecções da formação óssea - Google Patents

Medicamento para influenciar afecções da formação óssea

Info

Publication number
BR9510162A
BR9510162A BR9510162A BR9510162A BR9510162A BR 9510162 A BR9510162 A BR 9510162A BR 9510162 A BR9510162 A BR 9510162A BR 9510162 A BR9510162 A BR 9510162A BR 9510162 A BR9510162 A BR 9510162A
Authority
BR
Brazil
Prior art keywords
medication
bone formation
influence bone
formation disorders
disorders
Prior art date
Application number
BR9510162A
Other languages
English (en)
Inventor
Hans Dietl
Original Assignee
Orthomol Pharmazeutische Vertr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthomol Pharmazeutische Vertr filed Critical Orthomol Pharmazeutische Vertr
Publication of BR9510162A publication Critical patent/BR9510162A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BR9510162A 1995-02-01 1995-12-20 Medicamento para influenciar afecções da formação óssea BR9510162A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19503190A DE19503190A1 (de) 1995-02-01 1995-02-01 Mittel zur Beeinflussung von Störungen der Knochenbildung

Publications (1)

Publication Number Publication Date
BR9510162A true BR9510162A (pt) 1998-11-10

Family

ID=7752867

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9510162A BR9510162A (pt) 1995-02-01 1995-12-20 Medicamento para influenciar afecções da formação óssea

Country Status (8)

Country Link
US (1) US5985335A (pt)
EP (1) EP0806953B1 (pt)
JP (1) JP3712732B2 (pt)
BR (1) BR9510162A (pt)
CA (1) CA2211177C (pt)
DE (2) DE19503190A1 (pt)
ES (1) ES2158146T3 (pt)
WO (1) WO1996023504A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19503190A1 (de) * 1995-02-01 1996-08-08 Dietl Hans Mittel zur Beeinflussung von Störungen der Knochenbildung
GB9713620D0 (en) * 1997-06-28 1997-09-03 Boots Co Plc Composition
JP4592127B2 (ja) * 1999-03-30 2010-12-01 雪印乳業株式会社 骨吸収抑制剤
GB2370503A (en) * 2000-12-27 2002-07-03 Novartis Nutrition Ag Compositions comprising vitamin K
KR100875800B1 (ko) * 2001-03-15 2008-12-24 디에스엠 아이피 어셋츠 비.브이. 이소플라본과 다가 불포화 지방산의 혼합물을 포함하는골다공증 예방용 조성물
DE10135494A1 (de) * 2001-07-20 2003-11-06 Jobst Krauskopf Verwendung eines Lactatsalzes zur Behandlung und Prophylaxe der Athereosklerose
US20070077314A1 (en) * 2005-07-15 2007-04-05 Pak Charles Y C Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
ES2622281T3 (es) * 2007-08-09 2017-07-06 Novartis Ag Composiciones orales de calcitonina y sus aplicaciones
MY149641A (en) * 2008-06-03 2013-09-13 Biffin John Ray A method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530372A1 (de) * 1975-07-08 1977-01-13 Walter Dr Schweckendiek Pharmazeutische zubereitungen zur behandlung von psoriasis
JPS5218811A (en) * 1975-08-01 1977-02-12 Eisai Co Ltd Preparation of aqueous solution of fat- soluble substances
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
FR2600893B1 (fr) * 1986-07-01 1990-01-12 Sandoz Lab Nouvelles compositions pharmaceutiques a base de sels de calcium
IL89392A (en) * 1988-03-23 1993-02-21 Teva Pharmaceutical Ind Ltd Je Compositions for the treatment of osteoporosis in humans comprising 24, 25-dihydroxy-vitamin d3
WO1990003173A1 (en) * 1988-09-26 1990-04-05 Teijin Limited Stable aqueous preparation of active vitamin d¿3?
DE4111040C1 (pt) * 1991-04-05 1992-06-17 Deutsche Granini Gmbh & Co Kg, 4800 Bielefeld, De
BR9205983A (pt) * 1991-05-06 1994-08-02 Procter & Gamble Suplementos de cálcio e vitamina d combinados
CZ281823B6 (cs) * 1991-05-28 1997-02-12 The Procter And Gamble Company Minerální a vitaminový doplněk pro výstavbu kostí
JPH05213763A (ja) * 1992-02-10 1993-08-24 Sanwa Kagaku Kenkyusho Co Ltd 易吸収活性化カルシウム製剤
FR2704393B1 (fr) * 1993-04-30 1995-06-02 Boiron Complément nutritionnel absorbable pour optimiser la croissance et maintenir la solidité des os.
US5389391A (en) * 1993-05-10 1995-02-14 Monte; Woodrow C. Low pH antimicrobial food composition
US5780451A (en) * 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
WO1995028906A1 (fr) * 1994-04-20 1995-11-02 The Green Cross Corporation Recipient de perfusion, preparation d'un solute et solute vitamine hautement calorique complet
DE19503190A1 (de) * 1995-02-01 1996-08-08 Dietl Hans Mittel zur Beeinflussung von Störungen der Knochenbildung

Also Published As

Publication number Publication date
DE19503190A1 (de) 1996-08-08
CA2211177C (en) 2005-05-24
US5985335A (en) 1999-11-16
CA2211177A1 (en) 1997-10-15
JP3712732B2 (ja) 2005-11-02
JPH10513162A (ja) 1998-12-15
DE59509370D1 (de) 2001-08-02
WO1996023504A2 (de) 1996-08-08
EP0806953B1 (de) 2001-06-27
EP0806953A2 (de) 1997-11-19
ES2158146T3 (es) 2001-09-01
WO1996023504A3 (de) 1996-09-26

Similar Documents

Publication Publication Date Title
FI954402A (fi) Uusi farmaseuttinen tuote
NO20004345D0 (no) Farmasøytisk sammensetning
BR9610153A (pt) Formulações farmacêuticas
PT730864E (pt) Medicamento para tratar doencas inflamatorias cardiacas
BR9611626A (pt) Formulações farmacéuticas
FI973002A0 (fi) Terapeuttinen yhdiste - rasvahappokonjugaatit
NO973612L (no) Nytt farmasöytisk preparat
NO981967D0 (no) Stabile fryset÷rkede farmas÷ytiske formuleringer
DE59609238D1 (de) Aromengranulat
BR9610836A (pt) Composição antibacterial para administração oral
BR9610214A (pt) Compostos farmacéuticos
BR9605702A (pt) Alourante para cabelos humanos
BR9510162A (pt) Medicamento para influenciar afecções da formação óssea
BR9607626A (pt) Novos compostos farmacéuticos de naftila
LV11727A (lv) Farmaceitiska kompozicija
NO973610D0 (no) Nytt farmasöytisk preparat
FI973280A (fi) Farmaseuttinen koostumus
NO973611D0 (no) Nytt farmasöytisk preparat
BR9711981A (pt) Produto farmac-utico cristalino
FI951155A0 (fi) Farmaseuttinen valmiste
NO965448D0 (no) Farmasöytiske forbindelser
LV11966A (lv) Pretiekaisumu lidzeklis arigai lietosanai
BR9605777A (pt) Composição farmacêutica
NO964309D0 (no) Farmasöytisk sammensetning
KR950032276U (ko) 의약품 투여용 피부 흠집 형성구

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law